| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion. | Clin Cancer Res | 2006 | 1.42 |
| 2 | Prognostic factors in mesothelioma. | Lung Cancer | 2005 | 0.87 |
| 3 | Imaging in pleural mesothelioma: a review of the 11th International Conference of the International Mesothelioma Interest Group. | Lung Cancer | 2013 | 0.85 |
| 4 | BAK and NOXA are critical determinants of mitochondrial apoptosis induced by bortezomib in mesothelioma. | PLoS One | 2013 | 0.79 |
| 5 | Diffuse pleural mesothelioma with epithelioid and angiosarcomatous components--a hitherto undescribed pattern of differentiation. | Histopathology | 2012 | 0.75 |